يعرض 1 - 20 نتائج من 35 نتيجة بحث عن '(( binary a codon optimization algorithm ) OR ( library based research optimization algorithm ))', وقت الاستعلام: 0.58s تنقيح النتائج
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    SSA4LSMOP حسب Zongbin Qiao (19814199)

    منشور في 2024
    "…<p dir="ltr">SSA4LSMOP is a multi-objective optimization algorithm library, which aims to provide researchers and developers with efficient and easy-to-use multi-objective optimization solutions. …"
  7. 7

    Portable Library for Homomorphic Encrypted Machine Learning on FPGA Accelerated Cloud Cyberinfrastructure حسب Zhihan Xu (17049357)

    منشور في 2025
    "…This project will leverage our novel algorithmic, architectural, and memory optimizations on FPGAs to develop a portable library to enable secure and trustworthy ML inference. …"
  8. 8

    Portable Library for Homomorphic Encrypted Machine Learning on FPGA Accelerated Cloud Cyberinfrastructure حسب Zhihan Xu (17049357)

    منشور في 2024
    "…This project will leverage our novel algorithmic, architectural, and memory optimizations on FPGAs to develop a portable library to enable secure and trustworthy ML inference. …"
  9. 9

    <b>Portable Library for Homomorphic Encrypted Machine Learning on FPGA Accelerated Cloud Cyberinfrastructure</b> حسب Zhihan Xu (17049357)

    منشور في 2023
    "…This project will leverage our novel algorithmic, architectural, and memory optimizations on FPGAs to develop a portable library to enable secure and trustworthy ML inference. …"
  10. 10

    Otago's Network for Engagement and Research: Mapping Academic Expertise and Connections حسب Sander Zwanenburg (8552102)

    منشور في 2020
    "…Highlighted staff members can be emailed with the click of a button, allowing to easily bring together people with like-minded research expertise or interests.<br></div><div><br></div><div>In the next stage of the project, we will develop further the data integration schemes, enhance our algorithm to infer expertise based on this data, and update the interactive visualisation to reflect these inferences. …"
  11. 11

    PoseidonQ: A Free Machine Learning Platform for the Development, Analysis, and Validation of Efficient and Portable QSAR Models for Drug Discovery حسب Muzammil Kabier (21028487)

    منشور في 2025
    "…The advent of powerful machine learning algorithms as well as the availability of high volume of pharmacological data has given new fuel to QSAR, opening new unprecedented options for deriving highly predictive models for assisting the rationale design of new bioactive compounds, for screening and prioritizing large molecular libraries, and for repurposing new drugs toward new clinical uses. …"
  12. 12

    PoseidonQ: A Free Machine Learning Platform for the Development, Analysis, and Validation of Efficient and Portable QSAR Models for Drug Discovery حسب Muzammil Kabier (21028487)

    منشور في 2025
    "…The advent of powerful machine learning algorithms as well as the availability of high volume of pharmacological data has given new fuel to QSAR, opening new unprecedented options for deriving highly predictive models for assisting the rationale design of new bioactive compounds, for screening and prioritizing large molecular libraries, and for repurposing new drugs toward new clinical uses. …"
  13. 13

    PoseidonQ: A Free Machine Learning Platform for the Development, Analysis, and Validation of Efficient and Portable QSAR Models for Drug Discovery حسب Muzammil Kabier (21028487)

    منشور في 2025
    "…The advent of powerful machine learning algorithms as well as the availability of high volume of pharmacological data has given new fuel to QSAR, opening new unprecedented options for deriving highly predictive models for assisting the rationale design of new bioactive compounds, for screening and prioritizing large molecular libraries, and for repurposing new drugs toward new clinical uses. …"
  14. 14

    PoseidonQ: A Free Machine Learning Platform for the Development, Analysis, and Validation of Efficient and Portable QSAR Models for Drug Discovery حسب Muzammil Kabier (21028487)

    منشور في 2025
    "…The advent of powerful machine learning algorithms as well as the availability of high volume of pharmacological data has given new fuel to QSAR, opening new unprecedented options for deriving highly predictive models for assisting the rationale design of new bioactive compounds, for screening and prioritizing large molecular libraries, and for repurposing new drugs toward new clinical uses. …"
  15. 15

    PoseidonQ: A Free Machine Learning Platform for the Development, Analysis, and Validation of Efficient and Portable QSAR Models for Drug Discovery حسب Muzammil Kabier (21028487)

    منشور في 2025
    "…The advent of powerful machine learning algorithms as well as the availability of high volume of pharmacological data has given new fuel to QSAR, opening new unprecedented options for deriving highly predictive models for assisting the rationale design of new bioactive compounds, for screening and prioritizing large molecular libraries, and for repurposing new drugs toward new clinical uses. …"
  16. 16

    PoseidonQ: A Free Machine Learning Platform for the Development, Analysis, and Validation of Efficient and Portable QSAR Models for Drug Discovery حسب Muzammil Kabier (21028487)

    منشور في 2025
    "…The advent of powerful machine learning algorithms as well as the availability of high volume of pharmacological data has given new fuel to QSAR, opening new unprecedented options for deriving highly predictive models for assisting the rationale design of new bioactive compounds, for screening and prioritizing large molecular libraries, and for repurposing new drugs toward new clinical uses. …"
  17. 17

    PoseidonQ: A Free Machine Learning Platform for the Development, Analysis, and Validation of Efficient and Portable QSAR Models for Drug Discovery حسب Muzammil Kabier (21028487)

    منشور في 2025
    "…The advent of powerful machine learning algorithms as well as the availability of high volume of pharmacological data has given new fuel to QSAR, opening new unprecedented options for deriving highly predictive models for assisting the rationale design of new bioactive compounds, for screening and prioritizing large molecular libraries, and for repurposing new drugs toward new clinical uses. …"
  18. 18

    PoseidonQ: A Free Machine Learning Platform for the Development, Analysis, and Validation of Efficient and Portable QSAR Models for Drug Discovery حسب Muzammil Kabier (21028487)

    منشور في 2025
    "…The advent of powerful machine learning algorithms as well as the availability of high volume of pharmacological data has given new fuel to QSAR, opening new unprecedented options for deriving highly predictive models for assisting the rationale design of new bioactive compounds, for screening and prioritizing large molecular libraries, and for repurposing new drugs toward new clinical uses. …"
  19. 19

    PoseidonQ: A Free Machine Learning Platform for the Development, Analysis, and Validation of Efficient and Portable QSAR Models for Drug Discovery حسب Muzammil Kabier (21028487)

    منشور في 2025
    "…The advent of powerful machine learning algorithms as well as the availability of high volume of pharmacological data has given new fuel to QSAR, opening new unprecedented options for deriving highly predictive models for assisting the rationale design of new bioactive compounds, for screening and prioritizing large molecular libraries, and for repurposing new drugs toward new clinical uses. …"
  20. 20

    PoseidonQ: A Free Machine Learning Platform for the Development, Analysis, and Validation of Efficient and Portable QSAR Models for Drug Discovery حسب Muzammil Kabier (21028487)

    منشور في 2025
    "…The advent of powerful machine learning algorithms as well as the availability of high volume of pharmacological data has given new fuel to QSAR, opening new unprecedented options for deriving highly predictive models for assisting the rationale design of new bioactive compounds, for screening and prioritizing large molecular libraries, and for repurposing new drugs toward new clinical uses. …"